Details for Patent: 8,133,893
✉ Email this page to a colleague
Which drugs does patent 8,133,893 protect, and when does it expire?
Patent 8,133,893 protects OLEPTRO and DESYREL and is included in two NDAs.
This patent has thirty-two patent family members in twenty-three countries.
Summary for Patent: 8,133,893
Title: | Trazodone and trazodone hydrochloride in purified form |
Abstract: | A process of production of trazodone or trazodone hydrochloride that comprises the steps of: (a) preparing an organic phase comprising trazodone in at least one organic solvent; (b) preparing an aqueous phase comprising at least one basic compound; (c) mixing said aqueous phase with said organic phase; (d) heating at a temperature of at least 40.degree. C. for at least 30 minutes; (e) recovering said trazodone; and, optionally, (f) treating said trazodone with hydrochloric acid to obtain trazodone hydrochloride. Trazodone or trazodone hydrochloride comprising less than 15 ppm of alkylating substances, and a pharmaceutical composition comprising said trazodone hydrochloride. ##STR00001## |
Inventor(s): | Marchetti; Marcello (Rome, IT), Iacoangeli; Tommaso (Rome, IT), Ciottoli; Giovanni Battista (Rome, IT), Biondi; Giuseppe (Castel Gandolfo, IT) |
Assignee: | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. (Rome, IT) |
Application Number: | 12/513,048 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,133,893 |
Patent Claim Types: see list of patent claims | Compound; Composition; Use; Process; |
Drugs Protected by US Patent 8,133,893
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-001 | Feb 2, 2010 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
Angelini Pharma | OLEPTRO | trazodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022411-002 | Feb 2, 2010 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
Pragma | DESYREL | trazodone hydrochloride | TABLET;ORAL | 018207-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
Pragma | DESYREL | trazodone hydrochloride | TABLET;ORAL | 018207-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
Pragma | DESYREL | trazodone hydrochloride | TABLET;ORAL | 018207-003 | Mar 25, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,133,893
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Italy | MI2007A1603 | Aug 03, 2007 |
PCT Information | |||
PCT Filed | July 23, 2008 | PCT Application Number: | PCT/EP2008/059640 |
PCT Publication Date: | February 12, 2009 | PCT Publication Number: | WO2009/019133 |
International Family Members for US Patent 8,133,893
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 067773 | ⤷ Sign Up | |||
Australia | 2008285779 | ⤷ Sign Up | |||
Brazil | PI0814448 | ⤷ Sign Up | |||
Canada | 2693095 | ⤷ Sign Up | |||
China | 101772490 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |